Correlation Between Virax Biolabs and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Neurobo Pharmaceuticals.
Diversification Opportunities for Virax Biolabs and Neurobo Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virax and Neurobo is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.17 times more return on investment than Neurobo Pharmaceuticals. However, Virax Biolabs is 2.17 times more volatile than Neurobo Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 233.00 in Virax Biolabs Group on August 26, 2024 and sell it today you would lose (32.00) from holding Virax Biolabs Group or give up 13.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Virax Biolabs Group |
| Neurobo Pharmaceuticals |
Virax Biolabs and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Neurobo Pharmaceuticals
The main advantage of trading using opposite Virax Biolabs and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
| Neurobo Pharmaceuticals vs. Eliem Therapeutics | Neurobo Pharmaceuticals vs. HCW Biologics | Neurobo Pharmaceuticals vs. Scpharmaceuticals | Neurobo Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |